nonclinical strategies for oligonucleotide development programs
Published 7 years ago • 793 plays • Length 30:55Download video MP4
Download video MP3
Similar videos
-
25:14
regulatory applications of a nonclinical database for oligonucleotide therapeutics at u.s. fda
-
2:14
what are oligonucleotide therapeutics? - therapeutic oligonucleotides development
-
1:04:31
antisense oligonucleotide based therapies for inherited retinal diseases from mutation to clinical
-
23:35
antisense oligonucleotide therapy
-
54:11
shalini andersson: developing oligonucleotides into therapies
-
33:21
chemistry of therapeutic oligonucleotides: a brief overview
-
12:19
oligonucleotide-based therapeutics - creative biolabs
-
13:49
oligonucleotide therapeutics: new drugs that could stop covid-19
-
1:01:28
chemical and nanotechnology based approaches to build next gen oligonucleotide therapeutics
-
35:00
quantification methods for oligonucleotide therapeutics in serum and tissue
-
24:01
new approach for safety evaluation of oligonucleotide therapeutics using rnaseq
-
9:25
what are oligonucleotide therapeutics, and how do they work?
-
6:17
best practices for oligonucleotide therapeutic development: q&a
-
51:04
towards developing greener methods for oligonucleotide synthesis
-
2:03:11
education workshop (2021 annual meeting)
-
1:42
oligonucleotide-based therapeutics
-
59:20
anastasia khvorova: rnai-based therapeutics: 2018 outlook